Dr. Prash Puspanathan and Agnieszka Sekula | Source | Co-founders at enosis therapeutics
Dr. Prash Puspanathan and Agnieszka Sekula
Prash, a Medical Doctor and former Neuropsychiatry Fellow at The Alfred Hospital in Melbourne, is one of Australia’s leading advocates for accessible psychedelic-assisted psychotherapy. In this capacity, Prash is a Clinical Adviser to the Australian Psychedelic Society and is frequently sought for his thought leadership on the subject of the therapeutic uses of psychedelic substances. Prash is also the Founder of pioneering digital currency brokerage Caleb & Brown, named “Fintech Startup of the Year” in 2018 by the Australian Stockbrokers & Financial Advisors Association. Caleb & Brown, Australia’s largest personalized cryptocurrency brokerage firm, widens the suite of traditional wealth management services through the provision of bespoke digital currency solutions.
Agnieszka is a Scientist with background in Biomedical Engineering and Medical Imaging. She used cutting edge biotech tools, including customized imaging robots, 3D modelling and VR, to innovate medical research all over the world, including forensic medicine in Switzerland, space medicine in Austria and translational science in Singapore. She is currently a PhD candidate at the Centre for Human Psychopharmacology at Swinburne University in Australia. Agnieszka is devoted to science outreach, extensively advocating for open-science communication, community led research and outcome transparency.
-
enosis therapeutics
Co-founders
-
Enosis Therapeutics Generates Positive Results from World's First Study of the Synergistic Application of Virtual Reality and Psychedelics
Enosis Therapeutics, a medical technology and psychedelic research company that leverages virtual reality (VR) for the contextual modulation of psychedelic therapy to improve treatment outcomes, announced today the successful completion of the world's first study on the synergistic application of VR and psychedelics. The study, led by researchers and co-founders of Enosis Therapeutics, Agnieszka Sekula and Dr. Prash Puspanathan, was conducted in the Netherlands and in collaboration with Swinburn
Article -
Enosis Therapeutics Generates Positive Results from World's First Study of the Synergistic Application of Virtual Reality and Psychedelics
/PRNewswire/ -- Enosis Therapeutics, a medical technology and psychedelic research company that leverages virtual reality (VR) for the contextual modulation of...
Article
-
Enosis is rooted in evidence-based research that rigorously examines how technology can allow push the boundaries of what is considered possible in psychedelic-assisted psychotherapy. In contrast to passive scene-setting environments or interactive gaming-based scenarios, our data shows that by prioritizing a patient-centered experience design combined with carefully constructed clinical protocols, clinicians, scientists, therapists and institutions can utilize VR as a powerful new tool in their efforts to transform patients' lives.
-
The results of our inaugural study are an important first step in scientifically validating the use of VR scenarios in order to anchor key insights and emotions generated during the psychedelic therapy process. High levels of satisfaction, combined with therapeutic efficacy, paves the way for an increased focus on innovating context and environment in therapeutic protocols and shows that the implementation of VR may be an appealing solution for therapists, clinics or psychedelic companies.
